Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s)
β Scribed by S. Mark Redwood; Dr. Brian C.-S. Liu; Robert E. Weiss; Derrick E. Hodge; Michael J. Droller
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 1008 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Although more than 70% of human bladder cancer cases occur superficially, 15% to 30% of these cases progress to invasive disease. Superficial bladder carci-From the
π SIMILAR VOLUMES
Three cancer cell lines, IMC-2, IMC-3 and IMC-4, were established from a single tumor of a patient with maxillary cancer. We examined responses to epidermal growth factor (EGF) of these 3 cell lines with regard to cell growth and tumor invasion. The growth rate of IMC-2 in nude mice was markedly fas
Aberrant cellular signaling is a central feature of malignant cells and a potential target for anti-cancer therapy. Carboxyamido-triazole (CAI) is a calcium influx inhibitor that alters calcium-sensitive signal transduction pathways and suppresses the proliferative and metastatic potential of malign
## Abstract An antiserum was raised in rabbits by immunization with a human tumor cell line, Tβ24, derived from transitional cell carcinoma (TCC) of the urinary bladder. The specificity of the IgG fraction was assessed by antibodyβdependent cellular cytotoxicity (ADCC), using purified blood lymphoc
## METHODS. The authors used a polymerase chain reaction (PCR)-based telomeric repeat amplification protocol (TRAP) assay to determine the presence of te-Department of Urology, Mount Sinai School of lomerase activity in voided urine samples from patients with known but yet un-Medicine, New York, N